News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
163 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (31962)
Month
January (2854)
February (3083)
March (3049)
April (3166)
May (3576)
June (3256)
July (3084)
August (3051)
September (3627)
October (3996)
November (3760)
December (3171)
Day
1 (252)
2 (183)
3 (155)
4 (168)
5 (197)
8 (242)
9 (206)
10 (139)
11 (156)
12 (132)
15 (169)
16 (170)
17 (165)
18 (176)
19 (125)
22 (163)
23 (114)
24 (65)
29 (72)
30 (72)
31 (50)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
29
30
31
Drug Development
Achillion Pharmaceuticals, Inc. Shows Potential For “Best-In-Disease” HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422
December 22, 2014
·
9 min read
Drug Development
VBL Therapeutics Announces Positive Phase 2a Data For VB-111 In Recurrent Thyroid Cancer
December 22, 2014
·
5 min read
Business
Tekmira Establishes Manufacturing And Clinical Trial Agreement To Provide TKM-Ebola-Guinea For Clinical Studies In West Africa
December 22, 2014
·
10 min read
FDA
Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi)
December 22, 2014
·
5 min read
Pharm Country
Amicus Therapeutics, Inc. To Present Program Updates At 33rd Annual J.P. Morgan Healthcare Conference
December 22, 2014
·
2 min read
Business
Myriad Genetics, Inc. Names Bernard Tobin As President Of Crescendo Bioscience
December 22, 2014
·
7 min read
Drug Development
Can-Fite BioPharma Doses First Patient In Global Phase 2 Liver Cancer Trial For CF102
December 22, 2014
·
5 min read
Biotech Bay
Cutera, Inc. Commences Shipments Of Enlighten™
December 22, 2014
·
2 min read
Drug Development
Newly Released Peer-Reviewed Publication Further Validates RepliCel’s Use Of Dermal Sheath Cup Cells To Treat Pattern Baldness
December 22, 2014
·
6 min read
Pharm Country
Mederi Therapeutics Inc. Release: Groundbreaking Study Demonstrates Dramatic Histopathological Changes With Stretta And Secca
December 22, 2014
·
3 min read
Previous
8 of 17
Next
